Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 695-938-6 | CAS number: 678966-16-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 2015-03-04 to 2015-08-20
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 016
- Report date:
- 2016
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- 2004
- Deviations:
- no
- GLP compliance:
- no
- Remarks:
- non GLP, but in compliance with China National Metrology Accreditation
- Type of assay:
- mammalian erythrocyte micronucleus test
Test material
- Reference substance name:
- Lithium bis[ethanedioato(2-)-κO1,κO2]difluorophosphate(1-)
- EC Number:
- 695-938-6
- Cas Number:
- 678966-16-0
- Molecular formula:
- F2C4PLiO8
- IUPAC Name:
- Lithium bis[ethanedioato(2-)-κO1,κO2]difluorophosphate(1-)
- Test material form:
- solid: particulate/powder
Constituent 1
- Specific details on test material used for the study:
- Batch No.: 141104
Purity: 95.4%
Test animals
- Species:
- mouse
- Strain:
- ICR
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Zhejiang Center of Laboratory Animals, Hangzhou, Zhejiang
- Weight at study initiation: 25 - 30 g
- Assigned to test groups randomly: Yes
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 23 ± 3 °C
- Humidity (%): 40 - 70%
- Photoperiod (hrs dark / hrs light): 12 hours light /dark cycle
- Air changes (per hr): 10 - 12
Administration / exposure
- Route of administration:
- other: negative control group and the nominal treatmeht groups: gavage; positive controI group: intraperitoneaI injection
- Vehicle:
- - Vehicle used: Vegetable oil
- Concentration of test material in vehicle: 25, 50, 100 mg/kg - Details on exposure:
- PREPARATION OF DOSING SOLUTIONS: Solutions of the test substance in vegetable oil were prepared
- Duration of treatment / exposure:
- All mice were administered again 24h after the first dosing.
- Frequency of treatment:
- twice, with an interval 24 h
Doses / concentrationsopen allclose all
- Dose / conc.:
- 25 other: mg/kg
- Dose / conc.:
- 50 other: mg/kg
- Dose / conc.:
- 100 other: mg/kg
- No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent no treatment
- yes, concurrent vehicle
- Positive control(s):
- Cyclophosphamide
- Route of administration: Oral gavage
- Doses / concentrations: 40 mg/kg (dissolved in physiologic solution)
Examinations
- Tissues and cell types examined:
- Bone marrow from sternum
- Details of tissue and slide preparation:
- DETAILS OF SLIDE PREPARATION:
For the micronucleus assay, sternum was removed and marrow was aspirated from the bone and transferred to glass slides containing a drop of fetal calf serum. After the slides were allowed to air-dry, they were fixed in absolute methanol for 15 min, air-dried again. The bone marrow samples were stained with Giemsa solution. Briefly, Giemsa was prepared in a 1:9 solution with phosphate-buffered saline (PH 6.8), and slides were stained for approximately 20 min. The slides were then rinsed with phosphate-buffered saline (PH 6.8).
METHOD OF ANALYSIS:
Under a microscope, at least 2000 polychromatic erythrocytes (PCEs) per animal were examined for the presence of micronuclei. The frequency of micronucleated polychromatic erythrocytes (MNPCE) per 200 cells was calculated, and the ratio PCE/NCE was determined by counting a total of 200 erythrocytes. PCEs with more than one micronucleus were scored as a single MNPCE. The frequency of micronuclei in polychromatic cells provided an index of induced genetic damage. - Statistics:
- The frequency of micronucleated PCE (MNPCE/200) scores was transformed by the Square Root Transformation approach, and the normality of the distribution of the transformed date was assessed by means of the method of moments. The control and treated groups were then compared by using the Dunnett’s – test.
Results and discussion
Test results
- Key result
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- Clinical Signs / Mortality:
No clinical signs were observed in any test animal which could be suspected to be due to the test substance. And no death occurred in any test animal.
Micronucleus rate/ PCE/NCE ratio:
A statistically significant increase in the incidence of MNPCE and decrease in the polychromatic erythrocyte fraction over the control value was observed following treatment with the positive control substance cyclophosphamide ( P < 0.01), relative to the negative control in either male or female mouse bone marrow. The values for three treated doses for males and females did not reach statistical significance (p>0.05) when the treatment and negative control groups were compared.
Applicant's summary and conclusion
- Conclusions:
- No effects on the induction of MNPCE were observed with the test agent in three different doses for males and females.
- Executive summary:
The erythrocyte micronucleus test of the test substance in male and female ICR mice has been studied according to OECD Guideline 474.
25 male and 25 female ICR mice were randomly assigned to 5 groups. The positive controls were treated with cyclophosphamide at the concentration of 40 mg/kg and the negative controls received excipient only. The male and female sample groups were dosed with the test substance at doses of 25, 50 and 100 mg/kg twice, with an interval 24 h. Bone marrow was harvested 20h after the last dosing and analyzed for frequency of MNPCE. A minimum of 2000 polychromatic erythrocytes (PCEs) was analyzed for each animal. The ratio PCE / NCE was determined by counting a minimum of 200 erythrocytes (PCEs plus normachromatic erythrocytes [NCEs] ).
No clinical signs were observed in any test animal which could be suspected to be due to the test substance. And no death occurred in any test animal.
A statistically significant increase in the incidence of MNPCE and decrease in the polychromatic erythrocyte fraction over the control value was observed following treatment with the positive control substance cyclophosphamide ( P < 0.01), relative to the negative control in either male or female mouse bone marrow. The values for three treated doses for males and females did not reach statistical significance (p > 0.05) when the treatment and negative control groups were compared.
Results indicated that no effects on the induction of MNPCE were observed with the test agent in three different doses for males and females.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
